Trial · NCT02923921
Results by group12
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 12 of 12
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Overall Survival | Pegilodecakin + FOLFOX | 5.78 | 95% Confidence Interval 5.45 to 6.64 | Months | |
| Overall Survival | FOLFOX | 6.28 | 95% Confidence Interval 5.62 to 7.39 | Months | |
| Progression Free Survival | Pegilodecakin + FOLFOX | 2.14 | 95% Confidence Interval 1.94 to 3.38 | Months | |
| Progression Free Survival | FOLFOX | 2.10 | 95% Confidence Interval 1.94 to 3.25 | Months | |
| Percentage of Participants Achieving Complete Response (CR) or Partial Response (PR) [Objective Response Rate (ORR)] That Assessed by Investigator | Pegilodecakin + FOLFOX | 4.6 | Percentage of participants | ||
| Percentage of Participants Achieving Complete Response (CR) or Partial Response (PR) [Objective Response Rate (ORR)] That Assessed by Investigator | FOLFOX | 5.6 | Percentage of participants | ||
| Percentage of Participants With a Best Overall Response of Complete Response (CR), Partial Response (PR) or Stable Disease (SD): Disease Control Rate (DCR) | Pegilodecakin + FOLFOX | 42.8 | Percentage of participants | ||
| Percentage of Participants With a Best Overall Response of Complete Response (CR), Partial Response (PR) or Stable Disease (SD): Disease Control Rate (DCR) | FOLFOX | 36.6 | Percentage of participants | ||
| Duration of Response (DOR) | Pegilodecakin + FOLFOX | 4.99 | 95% Confidence Interval 3.45 to 7.06 | Months | |
| Duration of Response (DOR) | FOLFOX | 5.17 | 95% Confidence Interval 3.75 to 5.72 | Months | |
| Percentage of Participants Alive at 1 Year (12-Month Survival Rate) | Pegilodecakin + FOLFOX | 14.7 | 95% Confidence Interval 10.2 to 19.9 | Percentage of participants | |
| Percentage of Participants Alive at 1 Year (12-Month Survival Rate) | FOLFOX | 19.1 | 95% Confidence Interval 14.1 to 24.7 | Percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02923921/results